AI Drug-Discovery Firm Chai Raises $130 Million Series B
Summarize this article with:
Live on Bloomberg TVAI Drug-Discovery Firm Chai Raises $130 Million Series BBloomberg TechnologyTV ShowsDecember 15th, 2025, 9:03 PM GMT+0000Chai Discovery, an AI drug-discovery startup, raises a $130 million Series B at a $1.3 billion valuation, with plans to build a “computer-aided design suite” for molecules. Chai Discovery co-founder Joshua Meier and investor Elena Viboch, managing director at General Catalyst, join Caroline Hyde on “Bloomberg Tech.” (Source: Bloomberg)More From Bloomberg Technology05:02Legal Battles Over Trump’s $100,000 H-1B Visa Fee Heat Up23 minutes ago04:47AI Spending Anchoring Macroeconomy: Board’s Gallagher29 minutes ago44:05Broadcom Follows Oracle in Disappointing AI-Focused Investors | Bloomberg Tech 12/12/202504:19Fintech, AI Very Strong in UK: British Business Bank CEOAll episodes and clipsBloomberg Markets"Bloomberg Markets" is focused on bringing you the most important global business and breaking markets news and information as it happens.More episodes and clips06:39Trump to Ease Mileage Rules in Bid to Curb Rising Car Prices21:54Bloomberg Markets 12/15/202544:44Zelenskiy, European Leaders Meet | Balance of Power: Early Edition 12/15/202508:34Congress Faces Packed Agenda As Health Care Fight ContinuesThe David Rubenstein ShowThe David Rubenstein Show: Peer-to-Peer Conversations" explores successful leadership through the personal and professional choices of the most influential people in business.More episodes and clips24:06The David Rubenstein Show: Ynon Kreiz24:05David Rubenstein Show: Kevin Hassett24:05The David Rubenstein Show: Maria Sharapova24:06The David Rubenstein Show: Justice Anthony KennedySee all shows